SEVO Bioscience
PrivateLast Round
Angel
Sep 7, 2026
Total Funding Raised
$115,000
Momentum
Top 5%
of companies Caplight tracks
Company Overview
SEVO Bioscience operates in Healthcare & Life Sciences and is based in Montreal. Its latest recorded funding round was an Angel round in September 2026.
SEVO Bioscience is a synthetic biology company that develops microalgae-based oral vaccines and health solutions for the aquaculture industry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SEVO Bioscience Comparables
Compare SEVO Bioscience with similar companies based on industry and business-model similarity.
No comparables are published for SEVO Bioscience. Book a demo to ask about coverage.
Book a demoFor institutional investors. Book with your work email.
SEVO Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Angel | Sep 7, 2026 | ||||
| Grant | Jul 23, 2025 | ||||
| Grant | Feb 3, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
SEVO Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovacorp | Grant |
| Bioenterprise Canada | Grant |
| Cape Breton Capital Group | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 2, 2026
Open roles increased from 0 to 1, representing 25% of headcount.
- Sep 7, 2026
Cape Breton Capital Group led the round.
For institutional investors. Book with your work email.
SEVO Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SEVO Bioscience's valuation, stock price, and market status.
Is SEVO Bioscience a public or private company?
SEVO Bioscience is a private company.
What is the current stock price of SEVO Bioscience?
SEVO Bioscience is a private company, so its shares have no public market price. Caplight tracks SEVO Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SEVO Bioscience worth (valuation)?
Valuation information for SEVO Bioscience is not publicly available.
Can I buy SEVO Bioscience stock?
SEVO Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SEVO Bioscience's last funding round?
SEVO Bioscience's most recent funding round was Angel on September 7, 2026.
Who are the main investors in SEVO Bioscience?
Key investors in SEVO Bioscience include Cape Breton Capital Group.
Will SEVO Bioscience IPO soon?
No public IPO plans have been announced for SEVO Bioscience.
How can I track SEVO Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in SEVO Bioscience's shares on secondary markets.